NASDAQ:ICCC
ImmuCell Corporation Stock News
$5.05
+0 (+0%)
At Close: Apr 17, 2024
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
09:30am, Friday, 16'th Feb 2024
Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ET Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ET
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
12:15pm, Tuesday, 07'th Nov 2023
Conference Call Scheduled for Tuesday, November 14, 2023 at 9:00 AM ET Conference Call Scheduled for Tuesday, November 14, 2023 at 9:00 AM ET
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
12:00pm, Monday, 07'th Aug 2023
PORTLAND, Maine, Aug. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) Q1 2023 Earnings Call Transcript
10:00am, Friday, 12'th May 2023
ImmuCell Corporation (NASDAQ:ICCC ) Q1 2023 Earnings Conference Call May 12, 2023 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Conference Call Par
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
06:30am, Thursday, 04'th May 2023
PORTLAND, Maine, May 04, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets sc
ImmuCell Corporation (ICCC) Q4 2022 Earnings Call Transcript
12:50pm, Wednesday, 22'nd Feb 2023
ImmuCell Corporation (NASDAQ:ICCC ) Q4 2022 Earnings Conference Call February 22, 2023 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Conference Cal
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022
11:55am, Wednesday, 15'th Feb 2023
Conference Call Scheduled for Wednesday, February 22, 2023 at 9:00 AM ET Conference Call Scheduled for Wednesday, February 22, 2023 at 9:00 AM ET
ImmuCell Corporation (ICCC) Q3 2022 Earnings Call Transcript
11:37am, Tuesday, 22'nd Nov 2022
ImmuCell Corporation (NASDAQ:ICCC ) Q3 2022 Earnings Conference Call November 22, 2022 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Bobbi Jo Brock
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
09:00pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
PORTLAND, Maine, Sept. 14, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
05:00pm, Wednesday, 14'th Sep 2022
PORTLAND, Maine, Sept. 14, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2022 Results - Earnings Call Transcript
01:13pm, Friday, 12'th Aug 2022
ImmuCell Corporation (NASDAQ:ICCC ) Q2 2022 Earnings Conference Call August 12, 2022 9:00 AM ET Company Participants Joe Diaz - Investor Relations Michael Brigham - President and Chief Executive Offic
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
10:30am, Thursday, 04'th Aug 2022 GlobeNewswire Inc.
Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
06:30am, Thursday, 04'th Aug 2022
Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET Conference Call Scheduled for Friday, August 12, 2022 at 9:00 AM ET
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
12:05am, Thursday, 28'th Jul 2022 GlobeNewswire Inc.
PORTLAND, Maine, July 27, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
10:30am, Thursday, 07'th Jul 2022 GlobeNewswire Inc.
PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
